Pathogenetic elements of hepatitis E and animal models of HEV infection

Virus Research

Volumn 161, Issue 1, 2011, Pages 78-83

  Krawczynski, Krzysztof ^a   Meng, Xiang Jin ^b   Rybczynska, Jolanta ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

Author keywords

Animal models; Chimpanzees; HEV in pigs; Pathogenesis; Rhesus and cynomolgus macaques

Indexed keywords

CAPSID PROTEIN; HEPATITIS E VACCINE; VIRUS DNA;

CELL DEATH; CHICKEN; CHIMPANZEE; ENDEMIC DISEASE; HEPATITIS E; HUMORAL IMMUNITY; LIVER CELL; MACACA; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVIEW; RHESUS MONKEY; SPECIES ENDEMICITY; SWINE; VIREMIA; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; CHICKENS; DISEASE MODELS, ANIMAL; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; PRIMATES; RABBITS; RODENTIA; SWINE;

ANIMALIA; GALLUS GALLUS; MACACA; MIRIDAE; ORYCTOLAGUS CUNICULUS; PAN; PRIMATES; SUIDAE;

EID: 80053177571     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.03.007     Document Type: Review

References (66)

1. Aggarwal R., Kini D., Sofat S., Naik S.R., Krawczynski K. Duration of viraemia and faecal viral excretion in acute hepatitis E. Lancet 2000, 356:1081-1082.
2. Aggarwal R., Kamili S., Spelbring J., Krawczynski K. Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques. J. Infect. Dis. 2001, 184:1380-1385.
3. Aggarwal R., Shukla R., Jameel S., Agarwal S., Puri P., Patil A.P., Naik S. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J. Viral Hepat. 2007, 14:283-292.
4. Arankalle V.A., Ticehurst J., Sreenivasan M.A., Kapikian A.Z., Popper H., Pavri K.M., Purcell R.H. Aetiological association of a virus like particle with enterically transmitted non-A, non-B hepatitis. Lancet 1988, 1:550-554.
5. Arankalle V.A., Lole K.S., Deshmukh T.M., Srivastava S., Shaligram U.S. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine 2009, 27:1032-1039.
6. Balayan M.S., Andjaparidze A.G., Savinskaya S.S., Ketiladze E.S., Braginsky D.M., Savinov A.P., Poleschuk V.F. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 1983, 20:23-31.
7. Bhatia V., Singhal A., Panda S.K., Acharya S.K. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse?. Hepatology 2008, 48:1577-1585.
8. Billam P., Huang F.F., Sun Z.F., Pierson F.W., Duncan R.B., Elvinger F., Guenette D.K., Toth T.E., Meng X.J. Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens. J. Virol. 2005, 79:3429-3437. (Erratum 2006, J. Virol. 80, 6721).
9. Billam P., Pierson F.W., Li W., LeRoith T., Duncan R.B., Meng X.J. Development and validation of a negative-strand-specific reverse transcription-PCR assay for detection of a chicken strain of hepatitis E virus: identification of non liver replication sites. J. Clin. Microbiol. 2008, 46:2630-2634.
10. Bradley D.W., Krawczynski K., Cook E.H., McCaustland K.A., Humphrey C.D., Spelbring J.E., Myint H., Maynard J.E. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm virus like particles. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:6277-6281.
11. Chauhan A., Jameel S., Dilawari J.B., Chawla Y.K., Kaur U., Ganguly N.K. Hepatitis E virus transmission to a volunteer. Lancet 1993, 341:149-150.
12. Dawson G.J., Chau K.H., Cabal C.M., Yarbough P.O., Reyes G.R., Mushahwar I.K. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods 1992, 38:175-186.
13. Deshmukh T.M., Lole K.S., Tripathy A.S., Arankalle V.A. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine 2007, 25:4350-4360.
14. Emerson S.U., Zhang M., Meng X.J., Nguyen H., St Claire M., Govindarajan S., Huang Y.K., Purcell R.H. Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:15270-15275.
15. Favorov M.O., Fields H.A., Purdy M.A., Yashina T.L., Aleksandrov A.G., Alter M.J., Yarasheva D.M., Bradley D.W., Margolis H.S. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J. Med. Virol. 1992, 36:246-250.
16. Feagins A.R., Opriessnig T., Huang Y.W., Halbur P.G., Meng X.J. Cross species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus. J. Med. Virol. 2008, 80:1379-1380.
17. Graff J., Nguyen H., Yu C., Elkins W.R., St Claire M., Purcell R.H., Emerson S.U. The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J. Virol. 2005, 79:6680-6690.
18. Gupta D.N., Smetana H.F. The histopathology of viral hepatitis as seen in the Delhi epidemic (1955-56). Indian J. Med. Res. 1957, 45(Supplement):101-113.
19. Halbur P.G., Kasorndorkbua C., Gilbert C., Guenette D., Potters M.B., Purcell R.H., Emerson S.U., Toth T.E., Meng X.J. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J. Clin. Microbiol. 2001, 39:918-923.
20. Haqshenas G., Shivaprasad H.L., Woolcock P.R., Read D.H., Meng X.J. Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J. Gen. Virol. 2001, 82:2449-2462.
21. He J., Hoffman S.L., Hayes C.G. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine 1997, 15:357-362.
22. Huang W.J., Zhang H.Y., Harrison T.J., Lan H.Y., Huang G.Y., Wang Y.C. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4. Arch. Virol. 2009, 154:481-488.
23. Huang F., Zhang W., Gong G., Yuan C., Yan Y., Yang S., Cui L., Zhu J., Yang Z., Hua X. Experimental infection of Balb/c nude mice with Hepatitis E virus. BMC Infect. Dis. 2009, 9:93.
24. Huang Y.W., Haqshenas G., Kasorndorkbua C., Halbur P.G., Emerson S.U., Meng X.J. Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs. J. Virol. 2005, 79:1552-1558.
25. Huang Y.W., Opriessnig T., Halbur P.G., Meng X.J. Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo. J. Virol. 2007, 81:3018-3026.
26. Im S.W., Zhang J.Z., Zhuang H., Che X.Y., Zhu W.F., Xu G.M., Li K., Xia N.S., Ng M.H. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 2001, 19:3726-3732.
27. Johne R., Plenge-Bönig A., Hess M., Ulrich R.G., Reetz J., Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J. Gen. Virol. 2010, 91:750-758.
28. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., Cointault O., Eposito L., Abravanel F., Danjoux M., Durand D., Vinel J.P., Izopet J., Rostaing L. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 2008, 358:811-817.
29. Kamili S., Spelbring J., Carson D., Krawczynski K. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J. Infect. Dis. 2004, 189:258-264.
30. Khuroo M.S., Teli M.R., Skidmore S., Sofi M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am. J. Med. 1981, 70:252-255.
31. Krawczynski K., Bradley D.W. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J. Infect. Dis. 1989, 159:1042-1049.
32. Li X., Kamili S., Krawczynski K. Quantitative detection of hepatitis E virus RNA and dynamics of viral replication in experimental infection. J. Viral Hepat. 2006, 13:835-839.
33. Li T., Takeda N., Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001, 19:3476-3484.
34. Li S.W., Zhang J., Li Y.M., Ou S.H., Huang G.Y., He Z.Q., Ge S.X., Xian Y.L., Pang S.Q., Ng M.H., Xia N.S. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005, 23:2893-2901.
35. Li T.C., Suzaki Y., Ami Y., Tsunemitsu H., Miyamura T., Takeda N. Mice are not susceptible to hepatitis E virus infection. J. Vet. Med. Sci. 2008, 70:1359-1362.
36. Li W., Sun Q., She R., Wang D., Duan X., Yin J., Ding Y. Experimental infection of Mongolian gerbils by a genotype 4 strain of swine hepatitis E virus. J. Med. Virol. 2009, 81:1591-1596.
37. Longer C.F., Denny S.L., Caudill J.D., Miele T.A., Asher L.V., Myint K.S., Huang C.C., Engler W.F., LeDuc J.W., Binn L.N. Experimental hepatitis E: pathogenesis in cynomolgus macaques (Macaca fascicularis). J. Infect. Dis. 1993, 68:602-609.
38. Ma H., Zheng L., Liu Y., Zhao C., Harrison T.J., Ma Y., Sun S., Zhang J., Wang Y. Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses. PLoS One 2010, 5:e9160.
39. Malcolm P., Dalton H., Hussaini H.S., Mathew J. The histology of acute autochthonous hepatitis E virus infection. Histopathology 2007, 51:190-194.
40. Maneerat Y., Clayson E.T., Myint K.S., Young G.D., Innis B.L. Experimental infection of the laboratory rat with the hepatitis E virus. J. Med. Virol. 1996, 48:121-128.
41. McCaustland K.A., Krawczynski K., Ebert J.W., Balayan M.S., Andjaparidze A.G., Spelbring J.E., Cook E.H., Humphrey C., Yarbough P.O., Favorov M.O., Carson D., Bradley D.W., Robertson B.H. Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch. Virol. 2000, 145:1909-1918.
42. Meng X.J., Purcell R.H., Halbur P.G., Lehman J.R., Webb D.M., Tsareva T.S., Haynes J.S., Thacker B.J., Emerson S.U. A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9860-9865.
43. Meng X.J., Halbur P.G., Haynes J.S., Tsareva T.S., Bruna J.D., Royer R.L., Purcell R.H., Emerson S.U. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch. Virol. 1998, 143:1405-1415.
44. Meng X.J., Halbur P.G., Shapiro M.S., Govindarajan S., Bruna J.D., Mushahwar I.K., Purcell R.H., Emerson S.U. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J. Virol. 1998, 72:9714-9721.
45. Naik S., Aggarwal R., Naik S.R., Dwivedi S., Talwar S., Tyagi S.K., Duhan S.D., Coursaget P. Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian J. Gastroenterol. 2002, 21:149-152.
46. Niikura M., Takamura S., Kim G., Kawai S., Saijo M., Morikawa S., Kurane I., Li T.C., Takeda N., Yasutomi Y. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology 2002, 15:273-280.
47. Prusty B.K., Hedau S., Singh A., Kar P., Das B.C. Selective suppression of NF-κBp65 in hepatitis virus-infeted pregnant women manifesting sever liver damage and high mortality. Mol. Med. 2007, 13:518-526.
48. Pudupakam R.S., Huang Y.W., Opriessnig T., Halbur P.G., Pierson F.W., Meng X.J. Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo. J. Virol. 2009, 83:384-395.
49. Purcell R.H., Emerson S.U. Animal models of hepatitis A and E. ILAR J. 2001, 42:161-177.
50. Purcell R.H., Nguyen H., Shapiro M., Engle R.E., Govindarajan S., Blackwelder W.C., Wong D.C., Prieels J.P., Emerson S.U. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003, 21:2607-2615.
51. Renoux V.M., Fleury M.J., Bousarghin L., Gaitan J., Sizaret P.Y., Touzé A., Coursaget P. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Vaccine 2008, 26:6602-6607.
52. Shata M.T., Barrett A., Shire N.J., Abdelwahab S.F., Sobhy M., Daef E., El-Kamary S.S., Hashem M., Engle R.E., Purcell R.H., Emerson S.U., Strickland G.T., Sherman K.E. Characterization of hepatitis E-specific cell mediated immune response using IFN-gamma ELISPOT assay. J. Immun. Methods 2007, 328:152-161.
53. Soe S., Uchida T., Suzuki K., Komatsu K., Azumi J., Okuda Y., Iida F., Shikata T., Rikihisa T., Mizuno K. Enterically transmitted non-A, non-B hepatitis in cynomolgus monkeys: morphology and probable mechanism of hepatocellular necrosis. Liver 1989, 9:135-145.
54. Srivastava R., Aggarwal R., Jameel S., Puri P., Vijay K.G., Ramesh V.S., Bhatia S., Naik S. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol. 2007, 20:56-65.
55. Srivastava R., Aggarwal R., Bhagat M.R., Chowdhury A., Naik S. Alterations in natural killer cells and natural killer T cells during acute hepatitis E. J. Viral Hepat. 2008, 15:910-916.
56. Ticehurst J., Rhodes L.L., Krawczynski K., Asher L.V., Engler W.F., Mensing T.L., Caudill J.D., Sjogren M.H., Hoke C.H., LeDuc J.W. Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico. J. Infect. Dis. 1992, 165:835-845.
57. Tsarev S.A., Emerson S.U., Tsareva T.S., Yarbough P.O., Lewis M., Govindarajan S., Reyes G.R., Shapiro M., Purcell R.H. Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J. Infect. Dis. 1993, 167:1302-1306.
58. Tsarev S.A., Tsareva T.S., Emerson S.U., Kapikian A.Z., Ticehurst J., London W., Purcell R.H. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J. Infect. Dis. 1993, 168:369-378.
59. Tsarev S.A., Tsareva T.S., Emerson S.U., Yarbough P.O., Legters L.J., Moskal T., Purcell R.H. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J. Med. Virol. 1994, 43:135-142.
60. Tsarev S.A., Tsareva T.S., Emerson S.U., Rippy M.K., Zack P., Shapiro M., Purcell R.H. Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV. J. Infect. Dis. 1995, 172:31-37.
61. Williams T.P., Kasorndorkbua C., Halbur P.G., Haqshenas G., Guenette D.K., Toth T.E., Meng X.J. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J. Clin. Microbiol. 2001, 39:3040-3046.
62. Wu T., Zhang J., Su Z.J., Liu J.J., Wu X.L., Lin C.X., Ou S.H., Yan Q., Shih J.W.K., Xia N.S. Specific cellular immune response in hepatitis E patients. Intervirology 2008, 51:322-327.
63. Yu C., Boon D., McDonald S.L., Myers T.G., Tomioka K., Nguyen H., Engle R.E., Govindarajan S., Emerson S.U., Purcell R.H. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J. Virol. 2010, 84:11264-11278.
64. Zhang M., Emerson S.U., Nguyen H., Engle R., Govindarajan S., Blackwelder W.C., Gerin J., Purcell R.H. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 2002, 20:3285-3291.
65. Zhao C., Ma Z., Harrison T.J., Feng R., Zhang C., Qiao Z., Fan J., Ma H., Li M., Song A., Wang Y. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J. Med. Virol. 2009, 81:1371-1379.
66. Zhou Y.X., Lee M.Y., Ng J.M., Chye M.L., Yip W.K., Zee S.Y., Lam E. A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J. Gastroenterol. 2006, 14:306-312.